What is the Kiora Pharmaceuticals Inc. stock price forecast?

Kiora Pharmaceuticals Inc. is currently trading at $2.62. View real-time AI analysis on Alpha Lenz.

What is Kiora Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Kiora Pharmaceuticals Inc. on Alpha Lenz.

What is Kiora Pharmaceuticals Inc.'s P/E ratio?

View Kiora Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

Kiora Pharmaceuticals Inc.

NASDAQ · KPRX

$2.62+0.16(+6.50%)Pre-market

Ask about Kiora Pharmaceuticals Inc.'s future dividend policy...

Alpha Chat Insight

“Kiora Pharmaceuticals Inc.'s ROE is -51.7%. Explore profitability and growth together.”

Ask for details →

Company Overview

Kiora Pharmaceuticals Inc. is a biotechnology company focused on developing and commercializing therapies for eye disease. The company primarily works on innovative treatments aimed at addressing unmet medical needs in ophthalmology. Their research and product development are directed towards advancing therapies that can combat vision-related ailments such as eye inflammation and retinal diseases. By specializing in niche and complex eye conditions, Kiora Pharmaceuticals impacts the biotechnology and healthcare sectors, offering potential breakthroughs and improvements in treatment options. The company's commitment to biotechnology innovation provides vital contributions to therapeutic development within the pharmaceutical landscape, emphasizing targeted, patient-centric approaches in vision care.

CEODr. Brian M. Strem Ph.D.

Websitehttps://www.kiorapharma.com

SectorHealthcare

IndustryBiotechnology

Employees12

Company Statistics

FY 2025

Profile

N/AMarket Cap

$0.00Revenue

0.00Shares Out

12Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-35.68%ROA

-51.74%ROE

-39.83%ROIC

Financial Health

$8.70MCash & Cash Equivalents

$-569.81KNet Debt

50.39%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Kiora Pharmaceuticals Inc.'s ROE is -51.7%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Kiora Pharmaceuticals Inc. (ticker: KPRX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 12 employees.

The current price is $2.62 with a P/E ratio of -x and P/B of -x.

ROE is -51.74%.